

NCT01064752 Processed comparison:

Summary:
CHIA has 15 criteria while your personal folder has 18 criteria
Total found criteria: 13/15
Total not Found: 2/15
Total Extra: 3
This trial is INVALID



╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╕
│ CHIA Criteria                                     │ Matching Personal Criteria                        │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╡
│ HIV infection with plasma and CSF HIV RNA         │ HIV infection with plasma and CSF HIV RNA         │
│ concentrations (using Roche Amplicor assay) > 1   │ concentrations (using Roche Amplicor assay) > 1   │
│ 000 copies/ mL (available after baseline LP)      │ 000 copies/ mL (available after baseline LP)      │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Predicted adherence to the medication             │ Predicted adherence to the medication             │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Capable of providing informed consent             │ Capable of providing informed consent             │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ > 18 years old                                    │ > 18 years old                                    │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ When available subjects will be screened for      │ When available subjects will be screened for      │
│ stability of blood CD4 and HIV RNA levels         │ stability of blood CD4 and HIV RNA levels         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Taking a tetracycline within 6 months or history  │ Taking a tetracycline within 6 months or history  │
│ of adverse reaction to minocycline or another     │ of adverse reaction to minocycline or another     │
│ tetracycline                                      │ tetracycline                                      │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Enhanced risk from lumbar puncture including      │ Enhanced risk from lumbar puncture including      │
│ documented or suspected cerebral mass lesion      │ documented or suspected cerebral mass lesion      │
│ predisposing to brain herniation or bleeding      │ predisposing to brain herniation or bleeding      │
│ diathesis                                         │ diathesis                                         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Pregnancy or expectation of pregnancy during the  │ Pregnancy or expectation of pregnancy during the  │
│ study                                             │ study                                             │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Active opportunistic infection or active          │ Active opportunistic infection or active          │
│ neurological disease that might confound          │ neurological disease that might confound          │
│ evaluation                                        │ evaluation                                        │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ ADC Stage > 1                                     │ ADC Stage > 1                                     │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Hemoglobin < 10 Gms/dL                            │ Hemoglobin < 10 Gms/dL                            │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ BUN or creatine above the normal limits           │ BUN or creatine above the normal limits           │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┤
│ Taking other drugs known to reduce the metabolism │ Taking other drugs known to reduce the metabolism │
│ of minocycline and thus increase the probability  │ of minocycline and thus increase the probability  │
│ of toxicity                                       │ of toxicity                                       │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╛



╒═════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ CHIA Criteria Not Found in Personal                                                                 │
╞═════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Off antiretroviral therapy (ART) for > 6 weeks before the study and no plans to begin treatment for │
│ the study duration (The decision of whether or not a subject takes antiretroviral therapy will be   │
│ made by the subject in consultation with his/her primary care provider prior to screening for this  │
│ study )                                                                                             │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ CD4 cell counts >150 cells/μL (though likely most if not all will be >250 cells/μL)                 │
╘═════════════════════════════════════════════════════════════════════════════════════════════════════╛



╒═════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                             │
╞═════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ CD4 cell counts >150 cells/μL                                                                       │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Off antiretroviral therapy (ART) for > 6 weeks before the study and no plans to begin treatment for │
│ the study duration                                                                                  │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                   │
╘═════════════════════════════════════════════════════════════════════════════════════════════════════╛